Differential regulation of angiotensin peptides in plasma and kidney: Effects of adrenalectomy and estrogen treatment

被引:23
作者
Campbell, DJ
机构
关键词
angiotensin; renin; angiotensinogen; angiotensin converting enzyme; adrenalectomy; estrogen;
D O I
10.3109/10641969709083179
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Eight angiotensin peptides [angiotensin-(1-7), angiotensin II, angiotensin-(1-9), angiotensin I, angiotensin-(2-7), angiotensin-(2-8), angiotensin-(21-9), and angiotensin-(2-10)] were measured in plasma and kidney of adrenalectomized rats and estrogen-treated rats. In comparison with sham-operated rats, adrenalectomy increased plasma renin levels by 50-fold and reduced plasma angiotensinogen levels by 67%. Adrenalectomy increased plasma angiotensin peptide levels by 9- to 30-fold, but the increases in renal angiotensin peptide levels were much less than those seen for plasma. In comparison with vehicle-treated rats, estrogen treatment increased plasma angiotensinogen levels by 3-fold and reduced plasma renin levels by 41%. Estrogen treatment decreased plasma angiotensin peptide levels, whereas renal angiotensin peptide levels increased by as much as 2- to 3-fold. These results confirm the differential regulation of angiotensin peptide levels in plasma and kidney, and provide further support for the essential role of angiotensinogen in modulating plasma and tissue angiotensin peptide levels.
引用
收藏
页码:687 / 698
页数:12
相关论文
共 18 条
[1]   DIFFERENTIAL REGULATION OF ANGIOTENSIN PEPTIDE LEVELS IN PLASMA AND KIDNEY OF THE RAT [J].
CAMPBELL, DJ ;
LAWRENCE, AC ;
TOWRIE, A ;
KLADIS, A ;
VALENTIJN, AJ .
HYPERTENSION, 1991, 18 (06) :763-773
[2]   Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: Evidence that ACE inhibitors may inhibit a kininase other than ACE [J].
Campbell, DJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (12) :903-911
[3]   EFFECTS OF LOSARTAN ON ANGIOTENSIN AND BRADYKININ PEPTIDES AND ANGIOTENSIN-CONVERTING ENZYME [J].
CAMPBELL, DJ ;
KLADIS, A ;
VALENTIJN, AJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) :233-240
[4]   ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE TGR(MREN-2)27 RAT [J].
CAMPBELL, DJ ;
RONG, P ;
KLADIS, A ;
REES, B ;
GANTEN, D ;
SKINNER, SL .
HYPERTENSION, 1995, 25 (05) :1014-1020
[5]   EFFECTS OF CONVERTING-ENZYME INHIBITORS ON ANGIOTENSIN AND BRADYKININ PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1994, 23 (04) :439-449
[6]  
CAMPBELL DJ, 1993, RENIN ANGIOTENSION S
[7]   INFLUENCE OF CONVERTING-ENZYME INHIBITION ON RAT DES-ANGIOTENSIN I-ANGIOTENSINOGEN [J].
CLAUSER, E ;
BOUHNIK, J ;
GONZALEZ, MF ;
CORVOL, P ;
MENARD, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (02) :E129-E133
[8]   ANGIOTENSINOGEN PRODUCTION AND CONSUMPTION IN THE ADRENALECTOMIZED RAT [J].
CLAUSER, E ;
BOUHNIK, J ;
JARAMILLO, HN ;
AUZAN, C ;
CORVOL, P ;
MENARD, J .
ENDOCRINOLOGY, 1985, 116 (01) :274-280
[9]  
JOHANSEN KB, 1987, SCAND J CLIN LAB INV, V47, P411
[10]   DETERMINANTS OF ANGIOTENSIN-II GENERATION DURING CONVERTING ENZYME-INHIBITION [J].
JUILLERAT, L ;
NUSSBERGER, J ;
MENARD, J ;
MOOSER, V ;
CHRISTEN, Y ;
WAEBER, B ;
GRAF, P ;
BRUNNER, HR .
HYPERTENSION, 1990, 16 (05) :564-572